atai Life Sciences

Clinical trials sponsored by atai Life Sciences, explained in plain language.

atai Life Sciences ATAI NASDAQ

Biopharmaceutical company developing mental health treatments.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1 Completed 1

New pill shows promise for social anxiety in early trial

Symptom relief Completed

This study tested a new oral drug called EMP-01 in 70 adults with social anxiety disorder. Participants received either EMP-01 or a placebo for a short time to see if the drug is safe and helps reduce anxiety in social situations. The main goal was to check for side effects, whil…

Phase 2 • Sponsor: atai Therapeutics, Inc. • Aim: Symptom relief

Last updated Aug 02, 2026 00:00 UTC

atai Life Sciences

New pill shows promise for social anxiety in early trial